Nontherapeutic infant male circumcision is not medically or ethically justifiable and should be deferred until the person is able to decide for himself.
AMA J Ethics. 2017;19(8):815-824. doi:
10.1001/journalofethics.2017.19.8.msoc2-1708.
The Supreme Court’s ruling in Riegel v. Medtronic, Inc., may prevent consumers injured by medical devices that have FDA premarket approval from receiving compensation.
Specific advocate guidelines are needed for the protection of children in state custody who are potential research subjects in trials that would expose them to greater-than-minimal risk but also hold the prospect of direct benefit.
Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental.